logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Virgen del Rocío University Hospital

+34955012000
unidad.comunicacion.hvr.sspa@juntadeandalucia.es
Source: Site record.
http://hospitaluvrocio.es

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Hospital Universitario Virgen del Rocío, located on Avenida Manuel Siurot in the Bami neighborhood of Seville, Spain, is the largest healthcare complex in Andalusia and ranks among the most prestigious public hospitals in the country. Founded in 1955, this massive third-level medical hub is managed by the Andalusian Health Service (Servicio Andaluz de Salud) and operates with a workforce of nearly 10,000 healthcare and administrative professionals. The expansive campus is comprised of four specialized structures: the General Hospital, the Rehabilitation and Trauma Hospital, the Maternity and Children's Hospital, and the Duques del Infantado Hospital.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. General hospital
Source: Human-provided. Hospital
Source: Trial-derived.
709Total Trials
Source: Trial-derived.
148Recruiting Trials
Source: Trial-derived.
361Active Trials
Source: Trial-derived.
252Completed Trials
Source: Trial-derived.
858Unique Conditions
Source: Trial-derived.
439Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (24)Source: Trial-derived. Non-small Cell Lung Cancer (13)Source: Trial-derived. Acute Myeloid Leukemia (11)Source: Trial-derived. Chronic Lymphocytic Leukemia (10)Source: Trial-derived. Migraine (10)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (9)Source: Trial-derived. Obesity (9)Source: Trial-derived. Nonalcoholic Steatohepatitis (8)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (59)Source: Trial-derived. Eli Lilly and Company (52)Source: Trial-derived. Pfizer (43)Source: Trial-derived. Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (42)Source: Trial-derived. AbbVie (34)Source: Trial-derived. Merck Sharp & Dohme LLC (34)Source: Trial-derived. Gilead Sciences (28)Source: Trial-derived. Bayer (16)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported
Source: AI-inferred. Travel / lodging reimbursement coordination

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. CT Scan
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. PET-CT
Source: AI-inferred. Echocardiography
Source: AI-inferred. Spirometry
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Blood transfusion service
Source: AI-inferred. Lumbar puncture
Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Electronic participant diary (ePRO) system
Source: AI-inferred. Electronic patient diary (ePRO) system
Source: AI-inferred. Electronic patient-reported outcome (ePRO) system
Source: AI-inferred. Factor VIII inhibitor (Bethesda) assay
Source: AI-inferred. HLA typing
Source: AI-inferred. Left ventricular ejection fraction measurement
Source: AI-inferred. Minimal residual disease testing